Myrtelle’s rAAV-Olig001-ASPA Gene Therapy Candidate for Canavan Disease Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from the U.S. Food and Drug Administration
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…